Skip to main content
Supplement ScienceSupplementScience
I3C (Indole-3-Carbinol) supplement
Phytonutrient

I3C (Indole-3-Carbinol) — Research Profile

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

I3C from cruciferous vegetables promotes healthy estrogen metabolism by upregulating CYP1A1 enzymes that favor...

I3C from cruciferous vegetables promotes healthy estrogen metabolism by upregulating CYP1A1 enzymes that favor 2-hydroxylation of estrogens. Clinical doses of 200-400mg daily have been shown to improve estrogen metabolite ratios in human studies. I3C is the precursor to DIM, though its conversion in the stomach produces variable metabolite profiles.

Bottom line: I3C modulates estrogen metabolism at 200-400mg daily. DIM may be preferred for more predictable dosing and fewer GI effects.

Evidence:RCT (2000) · n=30 · moderate confidence[#1]. See full reference list below.

Key Facts

What it is
A phytochemical from cruciferous vegetables that converts to DIM and other active metabolites
Primary benefits
  • Modulates estrogen metabolism
  • Supports cervical cell health
  • Promotes detoxification pathways
  • May support breast tissue health
Typical dosage
200-400mg daily
Evidence level
Moderate
Safety profile
Generally Safe

Get the free evidence-based I3C (Indole-3-Carbinol) guide — delivered in 60 seconds.

No spam. Unsubscribe anytime.

What the Research Says

I3C has been studied for estrogen metabolism modulation since the early 1990s. Bradlow et al. first demonstrated its ability to shift estrogen metabolism toward 2-hydroxylation. A notable pilot study by Bell et al. (2000) in Gynecologic Oncology showed 50% regression of CIN 2-3 at 200-400mg daily over 12 weeks. However, the variable metabolite profile created during gastric acid conversion has led many practitioners to recommend DIM as a more predictable alternative.

Benefits of I3C (Indole-3-Carbinol)

  • Estrogen metabolism — 400mg daily increased the 2:16-hydroxyestrone ratio by approximately 50% in a 12-week RCT (Bradlow et al., 1991; Reed et al., 2005)
  • Cervical health — 200-400mg daily promoted regression of CIN in a pilot study of 30 women over 12 weeks (Bell et al., 2000)
  • Detoxification support — I3C upregulates Phase I and Phase II liver detoxification enzymes (CYP1A1, GST)
  • Antioxidant activity — I3C metabolites demonstrate free radical scavenging in cell-based assays
Did you know?

I3C has been studied for estrogen metabolism modulation since the early 1990s.

Forms of I3C (Indole-3-Carbinol)

I3C (Indole-3-Carbinol) supplement forms compared by bioavailability and best use
FormBioavailabilityBest For
I3C CapsulesModerate (pH-dependent conversion)General hormonal support — most common supplemental form
I3C + DIM CombinationModerate-HighComprehensive estrogen metabolism support — covers both precursor and active metabolite

Dosage Recommendations

General recommendation: 200-400mg daily in divided doses

Timing: Divided into two doses with meals • Take with food for best absorption.

Dosage by Condition

Estrogen metabolism
200-400mg dailyModerate
Cervical dysplasia support
200-400mg dailyEmerging
General detoxification
200mg dailyPreliminary

Upper limit: 400mg daily (higher doses increase GI side effects)

Side Effects and Safety

Safety profile: Generally Safe

Potential Side Effects

  • GI discomfort (nausea, bloating, gas) — more common than with DIM
  • Skin rash in sensitive individuals
  • Dizziness at higher doses
  • Equilibrium-related side effects reported at 800mg+ doses

Drug & Supplement Interactions

  • May reduce efficacy of estrogen-based medications and contraceptives
  • Induces CYP1A2 — may increase metabolism of caffeine, theophylline, and certain drugs
  • May interact with tamoxifen and other hormone therapies
Check I3C (Indole-3-Carbinol) interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

Commonly Taken Together

Related Supplements

Frequently Asked Questions

Should I take I3C or DIM?

DIM is generally preferred for targeted estrogen metabolism support because it provides the primary active metabolite directly, with more predictable dosing and fewer GI side effects [2]. I3C may be preferred when broader Phase I/II detoxification enzyme induction is desired, as it produces a wider range of metabolites beyond just DIM [1][2]. Some practitioners recommend a combination of both.

Evidence:RCT (2000) · n=30 · moderate confidence[#1]. See full reference list below.

How much broccoli would I need to eat to get a clinical dose of I3C?

You would need to eat approximately 1-2 pounds of raw cruciferous vegetables daily to obtain 200-400mg of I3C. Cooking reduces I3C content by 30-60%. Supplementation provides a far more practical and consistent dose than dietary intake alone.

Is I3C safe for long-term use?

Studies up to 12 weeks have shown I3C to be generally safe at doses up to 400mg daily. Long-term safety data beyond 12 weeks is limited. Some theoretical concerns exist about high-dose I3C promoting certain undesirable metabolites in the stomach. Periodic breaks or switching to DIM for long-term use is sometimes recommended by practitioners.

What is the best form of I3C (Indole-3-Carbinol) to take?

The best form of i3c (indole-3-carbinol) depends on your specific health goals, absorption needs, and tolerance. Chelated and standardized extract forms generally offer higher bioavailability than raw or unstandardized versions. Check the product label for third-party testing to ensure potency and purity.

What are the proven benefits of I3C (Indole-3-Carbinol)?

I3C (Indole-3-Carbinol) has been studied for multiple health applications with varying levels of clinical evidence. The strongest evidence typically comes from randomized controlled trials and meta-analyses published in peer-reviewed journals. Individual responses can vary based on baseline status, dosage, and duration of use.

How much I3C (Indole-3-Carbinol) should I take per day?

I3C (Indole-3-Carbinol) dosage depends on the specific form, your health goals, and individual factors such as body weight and baseline nutrient status. Following the dose used in clinical trials is generally the most evidence-based approach. Starting at the lower end of the recommended range and adjusting upward is advisable.

When is the best time to take I3C (Indole-3-Carbinol)?

I3C (Indole-3-Carbinol) timing depends on whether it is fat-soluble or water-soluble and whether it causes digestive sensitivity. Consistency in timing is more important than the specific hour of the day. Taking supplements at the same time daily helps maintain steady levels.

What are the side effects of I3C (Indole-3-Carbinol)?

I3C (Indole-3-Carbinol) is generally well tolerated at recommended doses, with gastrointestinal discomfort being the most commonly reported side effect. Side effects are typically mild and dose-dependent, resolving with dose reduction or taking with food. Serious adverse effects are rare at standard supplemental doses.

Does I3C (Indole-3-Carbinol) interact with any medications?

I3C (Indole-3-Carbinol) may interact with certain prescription medications by affecting absorption, metabolism, or pharmacological effects. Always inform your healthcare provider about all supplements you take, especially before surgery or when starting new medications. Spacing supplements and medications by 2 hours reduces most absorption interactions.

Who should consider taking I3C (Indole-3-Carbinol)?

I3C (Indole-3-Carbinol) is most appropriate for individuals with confirmed deficiency, suboptimal levels, or specific health conditions supported by clinical evidence. People in higher-risk demographics, including older adults and those with restricted diets, may benefit most. Testing baseline levels before supplementing provides the best guidance.

How long does I3C (Indole-3-Carbinol) take to show results?

I3C (Indole-3-Carbinol) effects vary by the specific health outcome being targeted, with some benefits appearing within days and others requiring weeks to months of consistent daily use. Correcting a deficiency typically shows improvement within 2-4 weeks. A minimum 8-12 week trial at the recommended dose is advisable before evaluating effectiveness.

Is I3C (Indole-3-Carbinol) safe for long-term daily use?

I3C (Indole-3-Carbinol) is considered safe for long-term use at recommended doses based on available clinical data. Staying within established upper intake limits minimizes the risk of adverse effects over time. Periodic reassessment with a healthcare provider is recommended, especially if health conditions change.

Can you take too much I3C (Indole-3-Carbinol)?

Exceeding the recommended dose of i3c (indole-3-carbinol) increases the risk of adverse effects without providing additional benefit. Toxicity risk varies by form and individual factors such as kidney and liver function. Mega-dosing is not supported by clinical evidence and should be avoided.

Can I combine I3C (Indole-3-Carbinol) with other supplements?

I3C (Indole-3-Carbinol) can generally be combined with complementary supplements, though some combinations may affect absorption or create additive effects. Spacing different supplements by 1-2 hours can reduce absorption competition. Consulting a healthcare professional is advisable when combining multiple supplements targeting the same health pathway.

What should I look for when buying a I3C (Indole-3-Carbinol) supplement?

Third-party testing from USP, NSF, or ConsumerLab is the most important quality indicator when purchasing i3c (indole-3-carbinol) supplements. Look for products that clearly state the specific form, dose per serving, and any relevant standardization percentages. Avoid proprietary blends that hide individual ingredient amounts.

Continue Reading

References

  1. RCTBell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM (2000). Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecologic Oncology. DOI PubMed
  2. RCTReed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, Sullivan DK, Mayo MS, Crowell JA, Hurwitz A (2005). Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane. Cancer Epidemiology, Biomarkers & Prevention. DOI PubMed